-- 根據週三提交給澳洲證券交易所的文件顯示，Emerald Resources（ASX：EMR）已獲得西澳大利亞州水務和環境監管部門對其全資擁有的丁戈嶺金礦項目的批准，該項目正式進入開發階段。 文件顯示，此次監管部門的批准涵蓋了關鍵基礎設施，包括選礦廠、發電站、尾礦庫以及未來黃金生產所需的配套工程。 文件還指出，該公司已完成並啟用了供施工和營運人員使用的現場住宿設施，並將持續鑽探至2026年，以支援資源更新，包括露天礦場的擴建和潛在的地下開發，同時推進首個礦石儲量的估算。 此外，文件補充道，該公司已承諾投資約3000萬澳元，用於為其丁戈嶺金礦項目購置兩台8000千瓦的美卓半自磨機以及一套破碎迴路。
Related Articles
Asia
Simcere Pharmaceutical Receives Chinese Regulatory Approval to Begin Trials of Tumor Drug
Simcere Pharmaceutical (HKG:2096) received Chinese regulatory approval to begin clinical trials of SIM0613, according to a Hong Kong bourse filing Wednesday.The injection is intended to treat advanced solid tumors and is licensed to Ipsen Pharma in regions outside Greater China.
$HKG:2096
Asia
Meitu Records 30% Rise in Paying Subscribers
Meitu (HKG:1357) said the number of paying subscribers using its platform grew 30% year on year to 17.90 million as of end March, according to a Hong Kong bourse filing Wednesday.Paying subscribers for the company's productivity tools grew 53% to 2.34 million, while leisure app subscribers increased 27% to 15.56 million, the firm said.The company's core revenue grew 34.3% year on year to 852 million yuan, while other businesses remained "stable overall."The company's annual recurring revenue for AI-driven productivity apps stood at 580 million yuan as of March, a 56% increase from a year earlier.
$HKG:1357
Asia
Yidu Tech Unit Wins SG$2.3 Million Singapore Healthcare Project
Yidu Tech (HKG:2158) said its subsidiary EVYD Research Private Limited won a contract from Singapore Health Services for the implementation and support of Dr Buddy, according to a Wednesday Hong Kong bourse filing.The total project amount is about SG$2.3 million.
$HKG:2158